QARA |
產品Products |
產品
Products
透顱微電治療(tDCS)
Transcranial
Direct Current Stimulation (tDCS)
HDC套件系統由一個程序主機(HDCprog),一個刺激器(HDC刺激)和標準電極片(HDCel)組成
HDCkit
system is composed by one programmer (HDCprog), one stimulator (HDCstim) and
standard electrodes (HDCel).
-
HDCprog
-
HDCstim
-
HDCel
-
MindCap
SAFETY
No evidence currently exists
of severe adverse reactions after tDCS in humans. Common adverse effects
include mild headache and an itching sensation at the electrode site. Skin
lesions (burns) have been reported after tDCS and considerable care is needed
in examining and preparing the skin-electrode interface. No reports describe
tDCS inducing seizures. The literature advises strongly against exceeding the
threshold of 0.05 mA/cm2 because ths intensity could cause a painful sensation
and tissue damage. In this way, the DC stimulation is far from the threshold
for tissue damage (14.3 mA/cm2) recently indicated for tDCS in an animal model.
Those intending to prescribe DC treatment should first read and understand the
scientific literature related to transcranial and trans-spinal DC stimulation.
設備描述:
Device Description:
非侵入性腦刺激,對認知障礙具有顯著的積極效果,並且可以改善神經精神症狀,例如抑鬱症。
tDCS,其中以微電流通過便攜式電池供電的刺激器通過兩個頭皮電極遞送。
tDCS,
where a weak electrical current is delivered through two scalp electrodes by a
portable battery-powered stimulator.
產品租用服務(首月免租)
詳情請聯絡我們
有限保養
-
QARA是香港唯一授權提供產品保養的機構。
-
HDCstim理療機: 2年保用
-
配備: 90日
報告下載服務
-
打印報告
-
客戶須攜帶主機到本公司
- 只供QARA購買HDCstim治療機的客戶。
Reference
material:
Elder and
Taylor Alzheimer's Research & Therapy
http://neuroci.com/wp-content/uploads/2016/03/Summary-of-tDCS-in-Dementia.pdf
專利信息
Patents Information:
於人類使用, 控制處方和施用經顱的直流電刺激治療裝置
Apparatus for the controlled
prescription and administration of transcranial direct current stimulation
treatments in humans
Patents Number: 專利號: WO
2009150687 A1